Qiaobing Xu's research interests lie at the intersection of material science engineering (specifically nanoscience) and biomedical applications. His work looks at developing new synthetic materials for the delivery of therapeutic biomacromolecules. In his postdoctoral research, Xu synthesized a library of lipid-like molecules, which were tested for efficacy both in vitro and in vivo in the delivery of protein and messenger RNA. Xu is currently investigating the use of drug delivery as a tool to stimulate host immune systems for cancer vaccine applications. Xu is also working on using micro/nanofabrication as tools for tissue engineering applications.
- 2020: Inducted Fellow, American Institute for Medical and Biological Engineering
- 2014: National Science Foundation CAREER Award
- 2013: Pew Scholar in Biomedical Sciences
- 2012: Charlton Award, Tufts School of Medicine
- 2011 and 2012: Tufts Collaboration grant
- 2010: Tufts Faculty Research Awards Committee award
- 2008-2010: MIT-Harvard Center for Cancer Nanotechnology Excellence postdoctoral fellowship
- 2002: Mary Fieser Graduate Research Grant, Harvard University
- Xu, Q., Wang, M. "Nanocomplexes for delivery of saporin," Patent pending, 61/822,586.
- Xu, Q., Wang, M. "Disulfide compounds for delivery of pharmaceutical agents," Patent pending, 61/770,657.
- Xu, Q., Wang, M. "Lysine-reactive anionic alkylating agents for protein and peptide delivery," Patent pending, 61/823,098.
- Xu, Q., "Two and three dimensional decellularized ECM constructs and uses therefore," Patent pending, 61/810,404.
- Alberti, K., Xu, Q. "Multilayered collagen tubular scaffold," PCT/US2012/064388.
- Xu, Q., Dai, X. "Nanostructures," US-2013-0177749-A1.
- Xu, Q., Bao, J., Capasso, F., Whitesides, G. "Fabrication of isolated nanostructures and/or arrays of nanostructures," PCT Int. Appl. 2008, PCT/US2007/007101.
- Cao, T., Xu, Q., Winkleman, A., Whitesides, G. "Methods and apparatuses for deposition of electrically-conductive and semiconductive nanofilms," PCT Int. Appl. 2007, 2007021741.